150 related articles for article (PubMed ID: 1657424)
1. Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.
Fischel JL; Formento P; Berlion M; Berille J; Gioanni J; Bizzari JP; Milano G
Cancer Chemother Pharmacol; 1991; 28(6):448-54. PubMed ID: 1657424
[TBL] [Abstract][Full Text] [Related]
2. [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
Fischel JL; Formento P; Berlion M; Berille J; Gioanni J; Bizzari JP; Milano G
Bull Cancer; 1992; 79(1):81-90. PubMed ID: 1520955
[TBL] [Abstract][Full Text] [Related]
3. Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines.
Fischel JL; Rostagno P; Formento P; Dubreuil A; Etienne MC; Milano G
Br J Cancer; 2001 Feb; 84(4):579-85. PubMed ID: 11207057
[TBL] [Abstract][Full Text] [Related]
4. Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.
Etienne MC; Bernard S; Fischel JL; Formento P; Gioanni J; Santini J; Demard F; Schneider M; Milano G
Br J Cancer; 1991 Mar; 63(3):372-7. PubMed ID: 2003979
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
[TBL] [Abstract][Full Text] [Related]
6. [Tamoxifen increases cytotoxic effects of fotemustine. Experimental results on cell lines of human melanoma].
Fischel JL; Barbé V; Berlion M; Formento P; Berrile J; Bizzari JP; Milano G
Bull Cancer; 1994 Jul; 81(7):599-604. PubMed ID: 7742602
[TBL] [Abstract][Full Text] [Related]
7. Wide range for optimal concentration of folinic acid in fluorouracil modulation--experimental data on human tumour cell lines.
Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Guillot T; Milano G
Eur J Cancer; 1994; 30A(10):1522-6. PubMed ID: 7833112
[TBL] [Abstract][Full Text] [Related]
8. Schedule-dependent interaction between raltitrexed and 5-fluorouracil in human colon cancer cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Yazawa Y; Tsunoda S; Furukawa Y
Oncol Res; 2000; 12(3):137-48. PubMed ID: 11216672
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen enhances the cytotoxic effects of the nitrosourea fotemustine. Results on human melanoma cell lines.
Fischel JL; Barbé V; Berlion M; Formento P; Berrile J; Bizzari JP; Milano G
Eur J Cancer; 1993; 29A(16):2269-73. PubMed ID: 8110498
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.
Pujol JL; Monnier A; Berille J; Cerrina ML; Douillard JY; Rivière A; Grandgirard A; Gouva S; Bizzari JP; Le Chevalier T
Br J Cancer; 1994 Jun; 69(6):1136-40. PubMed ID: 8198982
[TBL] [Abstract][Full Text] [Related]
11. Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor.
Fischel JL; Formento P; Etienne MC; Spector T; Renée N; Milano G
Biochem Pharmacol; 1997 Jun; 53(11):1703-9. PubMed ID: 9264323
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
13. Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.
Fischel JL; Etienne MC; Formento P; Milano G
Clin Cancer Res; 1998 Oct; 4(10):2529-35. PubMed ID: 9796987
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
Blomgren H; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions of 5-fluorouracil with either cisplatin or lobaplatin--a new, clinically active platinum analog in established human cancer cell lines.
Harstrick A; Vanhoefer U; Heidemann A; Druyen H; Wilke H; Seeber S
Anticancer Drugs; 1997 Apr; 8(4):391-5. PubMed ID: 9180394
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Tsunoda S; Ando J; Matsui J; Suzuki K; Ikeda T; Inoue Y; Adachi K
Br J Cancer; 1996 Sep; 74(5):704-10. PubMed ID: 8795571
[TBL] [Abstract][Full Text] [Related]
17. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
18. Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental results.
Lagrange JL; Fischel JL; Galliani S; Formento P; Guillot T; Bardon M; Milano G
Eur J Cancer; 1993; 29A(11):1531-5. PubMed ID: 8217357
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell lines.
Schiller JH; Bittner G
Int J Cancer; 1990 Jul; 46(1):61-6. PubMed ID: 2114374
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinoma.
Breul J; Tief G; Hartung R
Eur J Med Res; 1996 Apr; 1(7):339-42. PubMed ID: 9364036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]